Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae030 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Qingyang Xiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Society, Stockholm County Council.
Abstract (Originalsprache)
Background
Associations between germline alterations in women and cancer risks among their relatives are largely unknown.
Methods
We identified women from 2 Swedish cohorts Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) and prevalent KARMA (pKARMA), including 28 362 women with genotyping data and 13 226 with sequencing data. Using Swedish Multi-Generation Register, we linked these women to 133 389 first-degree relatives. Associations between protein-truncating variants in 8 risk genes and breast cancer polygenic risk score in index women and cancer risks among their relatives were modeled via Cox regression.
Results
Female relatives of index women who were protein-truncating variant carriers in any of the 8 risk genes had an increased breast cancer risk compared with those of noncarriers (hazard ratio [HR] = 1.85, 95% confidence interval [CI] = 1.52 to 2.27), with the strongest association found for protein-truncating variants in BRCA1 and 2. These relatives had a statistically higher risk of early onset than late-onset breast cancer (P = .001). Elevated breast cancer risk was also observed in female relatives of index women with higher polygenic risk score (HR per SD = 1.28, 95% CI = 1.23 to 1.32). The estimated lifetime risk was 22.3% for female relatives of protein-truncating variant carriers and 14.4% for those related to women in the top polygenic risk score quartile. Moreover, relatives of index women with protein-truncating variant presence (HR = 1.30, 95% CI = 1.06 to 1.59) or higher polygenic risk score (HR per SD = 1.04, 95% CI = 1.01 to 1.07) were also at higher risk of nonbreast hereditary breast and ovary cancer syndrome-related cancers.
Conclusions
Protein-truncating variants of risk genes and higher polygenic risk score in index women are associated with an increased risk of breast and other hereditary breast and ovary syndrome–related cancers among relatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Institute for Clinical Research and Systems Medicine, Health and Medical University, Potsdam, Germany.
- Department of Oncology, Södersjukhuset, Stockholm, Sweden.
ORCID-Profile: Qingyang Xiao, Xinhe Mao, Alexander Ploner, Felix Grassmann, Per Hall, Kamila Czene
Förderung
- Swedish Research Council
- Swedish Cancer Society
- Stockholm County Council
- China Scholarship Council
Zitieren
APA
Xiao, Q., Mao, X., Ploner, A., Grassmann, F., Rodriguez, J., Eriksson, M., Hall, P., & Czene, K. (2024). Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae030
Vancouver
Xiao Q, Mao X, Ploner A, Grassmann F, Rodriguez J, Eriksson M, et al. Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae030
BibTeX
@article{Xiao2024,
author = {Xiao, Qingyang and Mao, Xinhe and Ploner, Alexander and Grassmann, Felix and Rodriguez, Juan and Eriksson, Mikael and Hall, Per and Czene, Kamila},
title = {Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae030}
}
EUVIMED